Healthcare IT News December 13, 2022
Andrea Fox

The federal precision medicine initiative aiming to study the DNA of 1 million volunteers has announced that it has begun returning personalized health-related DNA results to more than 155,000 participants.

As part of its All of Us Research Program, the National Institute of Health will issue reports informing study participants if they have increased risks for certain health conditions – and givign them pharmacogenetic information that can indicate how their bodies might pocess certain medications.

Color Health has partnered with NIH to offer no-cost follow-up clinical DNA tests for those who request and receive results with pathogenic or likely pathogenic variants.

WHY IT MATTERS

Precision medicine seeks to individualize medical care by first understanding a person’s biological risk...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Patient-derived organoids: Transforming cancer research and personalized medicine

Share This Article